DatasetName,IVNS1ABP_S(2) IVNS1ABP_S(230) IVNS1ABP_S(246) IVNS1ABP_S(268) IVNS1ABP_S(269) IVNS1ABP_S(277) IVNS1ABP_S(28) IVNS1ABP_S(284) IVNS1ABP_S(322) IVNS1ABP_S(325) IVNS1ABP_S(326) IVNS1ABP_S(336) IVNS1ABP_S(338) IVNS1ABP_S(352) IVNS1ABP_S(39) IVNS1ABP_S(6),IVNS1ABP_T(281)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5263558210668017,
NJH2025_Sub12_HIIT_Mid,0.5192359451067294,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,0.5126465207699945,
NJH2025_Sub12_MICT_Pre,0.5208258127588568,
NJH2025_Sub7_MICT_Post,0.521021254763512,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.5288231624803641,
HS2024_6_B_T3,0.5145055592544918,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,0.5164042838843425,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,0.5216415627092096,
KBE2022_Log2_Ex_44_T,,
DB2022_Intensity L2,,
TM2022_mock.4h.C,0.5376917750603004,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5115378695373217,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,,
WZ2023_Pu_010_30min,,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,0.5191170268203482,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,0.5228638525677222,
KBE2022_Log2_Ex_14_U,,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5074588158190126,
JJ2018_Ratio H/L normalized___1,0.5190845224798353,
ZQ2022_C2,0.5208731757916376,
RB2022_5_PreSprint,0.5194336661787375,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,0.5365872268915456,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,0.5209924825657986,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,0.5125870888220072,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,0.5200318122818819,
TM2022_S2.4h.A,0.537570308571805,
RB2022_5_PostStrength,0.5320044570631419,
GF2025_P6_Sph,,
RB2022_2_PreSprint,0.5116004375728386,
ZX2022_CB treated Replicate 3,0.528734136532703,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,,
WZ2023_Pu_005_10min,,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,0.5187283714402185,
CK2022_9 40-1,0.5230749495294723,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.5043977047784308,
NJH2024_Sub4_HIIT_Pre,0.5199294659479627,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5185211848129385,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,0.49062382919683695,
CR2017_Ratio Replicate 1.3,0.5182087454476642,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,0.5177863543216077,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,0.5107549099067769,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,,
HS2024_3_B_N1,0.49477249077442975,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,,
CK2022_11 40-1,0.5230838655075594,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5243447103716733,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,,
NJH2024_Sub10_MICT_Post,0.5159914776058268,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.5280017163792325,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5199799360964991,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,0.5214187709622642,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.5227988741719447,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5088363083511106,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5076177029196502,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5253340364039052,
CK2022_1 200-1,0.5250323419841093,
PG2020_Intensity Mock_10h_D,0.5060022451584933,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5333441118127225,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,0.5068253680932854,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,,
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.5136856511241035,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,0.5372269322086534,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5175573334594735,
PG2020_Intensity 2h_C,,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5383143833816735,
KBE2022_Log2_Ex_8_T,,
NJH2025_Sub10_MICT_Post,0.5159914776058268,
HS2024_6_I_T3,0.5220266788547453,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.5194498467290514,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,0.5266071957502427,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,0.5199923810274742,
HS2024_4_I_T1,0.5104903189500523,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,0.5091941986723892,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.5128023425552162,
EJN2021_5_Rest_Basal,0.49829075305714166,
NJH2025_Sub2_HIIT_Post,0.5171563561548934,
NJH2025_Sub1_MICT_Post,0.519222786160825,
HS2024_9_B_T1,0.5362359633084058,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,0.5163010817299932,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5088751722494426,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,0.5164821097293409,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5227403052051052,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,0.5181758144293241,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,0.5068494245738315,
CF2017_EOC 3,0.5161276001108777,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.505185268836261,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5265139449005823,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5259245414041007,
KS2014_Intensity N3,0.5235532995896293,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,0.5108214761057889,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,0.5192359451067294,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.5561782948535869,
HS2024_8_PD_T1,0.5126171994497547,
JJ2018_Ratio H/L normalized pP2,0.5163645653410821,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5235621818291036,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.51657729106428,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5073741119638723,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,0.51937079192499,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,0.5207761622949401,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.5171552920535877,
NJH2024_Sub4_HIIT_Mid,0.5181493431651816,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,0.5087709744459481,
NJH2025_Sub4_MICT_Mid,0.5200318122818819,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,0.5199923810274742,
EP2017_Untreated R#4 log2 ratio,,
HS2024_6_B_N1,0.5065439472010604,
KBE2022_Log2_Ex_27_T,,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,0.5216415627092096,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),0.5239657986285438,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,0.5113583661642506,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5261824932200159,
RB2022_6_PreSprint,0.5170696716793287,
NJH2025_Sub12_MICT_Mid,0.5199278490298228,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,0.5201177132712673,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.5173696442714713,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,0.5102144887339816,
RN2012_H05,0.5174746677990282,
NJH2024_Sub7_HIIT_Mid,0.5199723989868916,
GF2025_P2_Adh,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,0.5176227693346246,
EJN2021_1_Rest_Ins,0.5127821918437977,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5168457592558615,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.5184107528281698,
CK2022_12 200-1,0.5166948828441243,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,0.5200862187888575,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,,
AH2018_TMTMS2_2_N,0.5086382886575423,
NJH2024_Sub13_MICT_Pre,0.5189271763047542,
KBE2022_Log2_Ex_41_U,,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),0.5102668629451076,
AH2018_TMTMS3_Pool,0.514427792980671,
KS2014_Intensity N4,0.5259266092585533,
NJH2024_Sub1_HIIT_Post,0.520128993613558,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,0.5186002026566352,
CF2017_OSE 26,,
CK2022_14 200-1,0.524415874729091,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,0.511635215369505,
TM2022_mock.4h.A,0.5378922282993597,
NJH2025_Sub12_HIIT_Pre,0.5204984658987023,
AH2018_TMTMS3_1_N,0.5140834104603136,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.5137567544708564,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,0.5201177132712673,
EJN2021_2_Rest_Ins,0.5130694678333385,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5261930271550108,
GF2025_P1_Adh,,
GF2025_P1_Sph,,
EJN2021_5_Ex_Basal,0.5133339671395135,
HS2024_7_I_T3,0.5068451738824137,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,,
CF2017_EOC 1,0.5213778916947225,
CK2022_3 200-1,0.5257444887069164,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,0.521437044602619,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,0.5174678090269614,
NJH2024_Sub13_MICT_Post,0.5180003826373604,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,0.5203648559065813,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5222919586900768,
HS2024_5_B_T1,0.5404982158881693,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5138336281226629,
RB2022_6_PreStrength,0.5085621522208418,
CK2022_2 40-1,0.5257502061755387,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5258316650959929,
JW2021_Before_2,,
TM2022_S2.12h.A,0.5363147662259353,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5258524519632969,
AR2021_ALG 1 μM,0.5127057693660181,
HS2024_4_B_T1,0.5126898457340312,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,0.5125834862098932,
NJH2025_Sub8_MICT_Post,0.5175728930733664,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5144268821033803,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,0.5218085821791667,
NJH2024_Sub6_HIIT_Post,0.51929170001761,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5248282586414912,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5046250787777727,
CK2022_16 16-1,0.5253455384259358,
FS2019_db/db3,,
CK2022_15 40-1,0.5255672502913099,
NJH2024_Sub9_MICT_Pre,0.5199190211050462,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.49553509558075093,
AH2018_TMTMS3_3_X,0.5124355645978891,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,0.5176046965964194,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,0.5042531274689199,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,0.5186002026566352,
PG2020_Intensity CT_D,,
NJH2025_Sub9_MICT_Post,0.5192758282638815,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5181423225952411,
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,0.519222786160825,
HS2024_3_I_T2,0.5219878885868391,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5097946046693564,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5233546871448542,
NJH2024_Sub12_HIIT_Pre,0.5204984658987023,
NJH2024_Sub8_MICT_Pre,0.5171932814038454,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,0.5024210179031013,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5080309402695671,
GF2025_P3_Adh,,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5089134627777132,
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,0.5194055173473512,
TM2022_S2.12h.C,0.5370611165208395,
NJH2025_Sub9_MICT_Mid,0.5193126183595269,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,0.5168355981482816,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,0.49887552879838315,
RB2022_7_RecoverySprint,0.5066826405775405,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.516869280778368,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.511214918491263,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5303560079991235,
NJH2025_Sub6_HIIT_Pre,0.5163010817299932,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5180899731418216,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.5269876502954542,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,0.5175728930733664,
AH2018_TMTMS3_3_C,0.5146043189491958,
KBE2022_Log2_Ex_9_U,,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,0.520128993613558,
DL2023_24h-2,,
HS2024_7_B_N2,0.5038711060676444,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,0.5160939751016805,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,0.5189963680011482,
CK2022_8 40-1,0.5266063152812177,
RB2022_7_RecoveryEndurance,0.5221233013235091,
NJH2025_Sub12_HIIT_Post,0.521437044602619,
EJN2021_4_Ex_Basal,0.5129405583651407,
TM2022_S2.12h.B,0.5362624044496651,
RN2012_L15,,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,0.5380757410575044,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,0.5365660142436869,
KBE2022_Log2_Ex_24_U,,
NJH2025_Sub13_MICT_Mid,0.5181758144293241,
KS2014_Intensity C3,0.5088461461663466,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.5387100535874855,
CK2022_7 200-1,0.5261832114179819,
CK2022_5 200-1,0.5258488108339293,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,0.5161436374792175,
RB2022_2_PostEndurance,0.5189360939620038,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,0.513192627220403,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.5262940787513477,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,0.5075648327216183,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.5168138513230481,
NJH2024_Sub7_MICT_Mid,0.5209924825657986,
PG2020_Intensity 6h_B,,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,0.5186501484813305,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,0.5209782758100464,
HS2024_6_B_N2,0.5200526431163174,
KBE2022_Log2_Ex_9_T,,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.5106828608648105,
UK2020_UA_2,0.5121303803619911,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,0.5169600745572822,
AH2018_TMTMS2_3_N,0.507120793905754,
RN2012_H06,,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.4997373446146669,
WZ2023_Su_005_30min,,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,0.5122760774049819,
NJH2024_Sub10_HIIT_Post,0.5162267694182342,
CR2017_Ratio Replicate 3.1,0.5141996923141126,
WZ2023_Su_025_10min,,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,,
NJH2025_Sub6_HIIT_Post,0.51929170001761,
RB2022_6_RecoverySprint,0.5133583037550206,
KS2014_Intensity,0.5166266518375309,
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.48610491345403944,
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,,
RN2012_L10,0.5079496031048638,
PG2020_Intensity 4h_C,0.5112284459622519,
EP2017_Mitotic R#3 normalized log2 ratio,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,,
RB2022_8_PostStrength,0.5159849277618358,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.5177196123291271,
NJH2024_Sub2_HIIT_Post,0.5171563561548934,
HS2024_8_B_N2,0.49874759052769274,
NJH2025_Sub8_HIIT_Pre,0.5168355981482816,
JJ2018_Ratio H/L normalized pP2___1,0.5163934319484255,
HS2024_8_I_T2,0.5055928394592185,
KBE2022_Log2_Ex_6_U,,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5164070325669357,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5245517662294351,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,,
GF2025_P9_Sph,,
CK2022_6 200-1,0.5260778847775827,
NJH2024_Sub7_MICT_Post,0.521021254763512,
AH2018_TMTMS3_2_X,0.5153264995011211,
NJH2024_Sub8_HIIT_Post,0.5175068858525774,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.49414295257758073,
NJH2024_Sub2_MICT_Mid,0.5209782758100464,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5040516060253679,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,0.5194055173473512,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.4987067708472791,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,0.5189271763047542,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,
EP2017_Untreated R#3 normalized log2 ratio,,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,0.5209825171487399,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5255829458058395,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5089900757649287,
RB2022_7_PostEndurance,0.51392805521731,
NJH2025_Sub4_HIIT_Pre,0.5199294659479627,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,0.5365407569690784,
JJ2018_Ratio H/L normalized pP1,0.5197310250867022,
EP2017_Pervanadate R#2 normalized log2 ratio,,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5106076324321737,
KBE2022_Log2_Ex_29_T,,
HS2024_7_I_T2,0.5019121553048642,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.510479049410023,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,0.5123973726244438,
FR2021_Intensity.M,,
RB2022_2_PostSprint,0.5131014671303169,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.518230407871076,
PG2020_Intensity CT_C,,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,,
EP2017_Untreated R#3 log2 ratio,,
RB2022_2_PostStrength,0.5155588645089643,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5101857353482141,
HS2024_8_PD_T2,0.49345648954729326,
FS2019_Ctr2,,
RB2022_6_PreEndurance,0.4995604520356942,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,0.51937079192499,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.5045659602748186,
NJH2025_Sub10_MICT_Mid,0.5174678090269614,
KBE2022_Log2_Ex_15_U,,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5252629861606684,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,0.5180003826373604,
HS2024_4_B_N2,0.501358224637872,
HS2024_3_PD_T3,0.507684814573493,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,0.5154613376408035,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.5237757747344755,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,,
CK2022_2 16-1,0.5249875626234801,
RAM2015_Log2 B,0.5331561785503498,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,0.5171932814038454,
EJN2021_4_Rest_Basal,0.4975852257030454,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5138675225046411,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5208638591182624,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,0.5162267694182342,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.5078944720430952,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,0.5157218364458934,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,0.5016751550753826,
HS2024_8_I_N1,0.5136230604757587,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,0.5023623475593716,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5304724834905188,
NJH2025_Sub7_HIIT_Mid,0.5199723989868916,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,0.5116370109573107,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5140094253982375,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,0.5063951919952714,
KS2014_Intensity C5,0.5253305573038887,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,0.5211707770413034,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,0.5371611451437068,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,0.5200720186890049,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5193942045110912,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,0.5168607095151628,
PG2020_Intensity 8h_B,0.5080398693641736,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.511789773829517,
GF2025_P3_Sph,,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,0.5207761622949401,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),0.5154234102658574,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5182636156683939,
CR2017_Ratio Replicate 2.4,0.5152440490342234,
ZQ2022_N1,0.510427449579189,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,0.5127886723827018,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,0.5210323444771839,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,0.5129250278599935,
KBE2022_Log2_Ex_13_U,,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5163229973992041,
CK2022_7 40-1,0.5269576972837882,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,0.5161436374792175,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.5190498068462828,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5258838216154297,
WZ2023_Su_025_20min,,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,0.5211707770413034,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.5261824932200159,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5271298168915792,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,0.5086958837670645,
HS2024_3_B_N2,0.5030927774510097,
EJN2021_4_Ex_Ins,0.5115074327419493,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,0.5080965380219626,
EP2017_Pervanadate R#3 log2 ratio,,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,0.5181493431651816,
RCJD2014_5min_2,,
RB2022_6_PostStrength,0.5207937935152558,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,0.5176193474985485,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,0.520628872892062,
NJH2025_Sub6_MICT_Post,0.5189963680011482,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5135361928458567,
CK2022_6 40-1,0.526979077013296,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,,
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,0.5094511870044877,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,,
HS2024_8_PD_T3,0.48383564382282535,
EJN2021_3_Ex_Basal,0.5125244362982548,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,,
NJH2025_Sub4_MICT_Post,0.5191170268203482,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.5491004801174939,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.508440415327428,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.5138256090449675,
HS2024_8_I_N2,0.5211795070156476,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,0.5187744539482632,
AH2018_SILAC_M_1_C,,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,0.5241324526360239,
JJ2018_Ratio H/M normalized pP2___1,0.5126487266650926,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),0.5128867850109735,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,0.520628872892062,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,0.5192137911445472,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5155386683098558,
LY2019_P2-,,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,0.5163656667183243,
RB2022_8_RecoveryStrength,0.50471634570944,
WZ2023_Pe_005_20min,,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,0.5161209209140261,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5143310979418151,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.52741064143404,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,0.5176193474985485,
NJH2024_Sub9_MICT_Post,0.5192758282638815,
CF2017_OSE 28,,
HS2024_5_B_T2,0.5063787200798966,
HS2024_6_I_T1,0.5201444405009407,
HS2024_5_B_T3,0.5245024739564501,
JJ2018_Ratio H/M normalized pP1___1,0.515466720701579,
KBE2022_Log2_Ex_36_U,,
AH2018_TMTMS3_3_N,0.5135326688847714,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,0.5203648559065813,
NJH2025_Sub8_HIIT_Mid,0.5168607095151628,
EP2017_Mitotic R#3 log2 ratio,,
KBE2022_Log2_Ex_36_T,,
NJH2025_Sub6_HIIT_Mid,0.5187744539482632,
WZ2023_Pu_005_30min,,
KS2014_Intensity C2,0.5160360876695678,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,,
CK2022_9 200-1,0.5180119658118062,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5181059741982353,
NJH2024_Sub9_MICT_Mid,0.5193126183595269,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5169634571413616,
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5118959142894526,
HS2024_3_I_T3,0.506747254192984,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5264564639279073,
ZQ2022_C3,0.5201618440392105,
EJN2021_3_Rest_Ins,0.5058014198579535,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,0.5200862187888575,
KBE2022_Log2_Ex_39_T,,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,,
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,,
NJH2025_Sub9_HIIT_Mid,0.5187283714402185,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5322629342265187,
KS2014_Intensity N1,0.5027160237050996,
NJH2024_Sub12_MICT_Post,0.5210323444771839,
TM2022_S2.8h.C,0.5367439673902727,
CR2017_Ratio Replicate 1,0.5021687302592198,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5139253629205024,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,0.5161209209140261,
NJH2025_Sub13_HIIT_Post,0.5197828395085977,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,0.5152753138480344,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.49931117138008674,
HS2024_5_I_N1,0.5035142895273219,
HS2024_6_I_N1,0.486489852475038,
AR2021_KD 48h,0.5172609112161924,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.544306568196315,
NJH2024_Sub10_MICT_Pre,0.5177666562322885,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,,
KBE2022_Log2_Ex_29_U,,
HS2024_7_B_T1,0.5177418276331148,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.5247366858765952,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5153501274790558,
JJ2018_Ratio M/L normalized pP3___1,0.5177863543216077,
KBE2022_Log2_Ex_34_T,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5244873586815623,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,,
RN2012_H01,0.511956590479853,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,0.5128607120592455,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,,
HS2024_8_B_T3,0.5186465707717385,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,,
WZ2023_Pe_010_20min,,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.524496817687162,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,,
PG2020_Intensity 6h_C,0.5086069802296467,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.5181533320169117,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5076440193738709,
CK2022_15 16-1,0.5254358106056278,
CK2022_3 16-1,0.5252923434685408,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5108727825413173,
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,
CK2022_10 16-1,0.5217632345996814,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),0.5241391521181169,
NJH2024_Sub2_HIIT_Mid,0.5189950371604374,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,0.5164042838843425,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,0.5199278490298228,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,0.513189375218925,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,,
EJN2021_2_Ex_Basal,0.5126050803670567,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5193254018696248,
AR2021_L41 10 μM,0.5053517069658087,
CF2017_EOC 2,0.515556141778256,
RB2022_6_PostEndurance,0.5113533214070777,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,0.5154613376408035,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,0.5131612454893104,
NJH2024_Sub2_MICT_Pre,0.5200720186890049,
HS2024_3_PD_T2,0.4916950209537577,
CK2022_6 16-1,0.5258345821956858,
ZX2022_CB treated Replicate 1,0.5398163198740618,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,0.5359258411411018,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5081528968211755,
AR2021_L41 1 μM,0.517600015182717,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5077733576913935,
NJH2025_Sub10_MICT_Pre,0.5177666562322885,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5263222000977517,
KS2014_Intensity C4,0.5226109869912391,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,,
NJH2025_Sub9_MICT_Pre,0.5199190211050462,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.51850319120718,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,0.5189950371604374,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,0.5093384740613232,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5142325174894294,
JJ2018_Ratio H/L normalized pP1___1,0.5181810682447052,
WZ2023_Pe_010_30min,,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.5242926651698806,
ZQ2022_N3,0.5076651468491439,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5217730640807721,
NJH2024_Sub7_MICT_Pre,0.5214187709622642,
ZX2022_Control Replicate 1,0.5317085447034884,
JJ2018_Ratio H/M normalized pP1,0.5155797045353276,
CK2022_16 40-1,0.5255594969636165,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,0.5267522878908831,
AH2018_LFQ_3_X,,
UK2020_UA_3,0.5119850518067167,
LY2019_P7-,,
GF2025_P5_Adh,,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5273775837373015,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.5222559497902339,
ZQ2022_C1,0.5209065752254035,
CR2017_Ratio Replicate 2.1,0.5195441763544181,
PG2020_Intensity CT_B,,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,0.5192137911445472,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,0.5175068858525774,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,
RB2022_2_PreEndurance,0.5184762169317747,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.518678854554909,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5261576049412096,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5222175049806805,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,,
AH2018_TMTMS2_1_X,0.5073746778695156,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,0.5160939751016805,
EJN2021_5_Ex_Ins,0.5109050812903143,
HS2024_6_I_N2,0.5061499331413872,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,0.5358895862110693,
NJH2024_Sub12_MICT_Pre,0.5208258127588568,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5183025852259165,
HS2024_4_I_T3,0.5110742532261453,
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,0.5139702299111405,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,0.5197828395085977,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,0.5209825171487399,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5053155906457585,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,,
EP2017_Untreated R#2 normalized log2 ratio,,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,0.5273330570938125,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,,
AS2011_Ratio H/L Normalized RNAi_2_1,,
